开云app官网登录入口网页版-官方正版

#临床实验#

34篇内容 | 1241人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1941573, encodeId=642c19415e377, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=ASCO2022：机会之窗临床实验，胶质母细胞瘤的曙光, objectType=article, longId=728706, objectId=41d8e2870685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41d8e2870685, replyNumber=0, likeNumber=87, createdTime=2022-06-24, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41d8e2870685, moduleTitle=ASCO2022：机会之窗临床实验，胶质母细胞瘤的曙光, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=41d8e2870685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941572, encodeId=182419415e2c8, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Nat Med：摇头丸治疗创伤后应激障碍PTSD的三期临床实验结果发布, objectType=article, longId=211418, objectId=b662211418c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b662211418c8, replyNumber=0, likeNumber=68, createdTime=2021-06-21, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b662211418c8, moduleTitle=Nat Med：摇头丸治疗创伤后应激障碍PTSD的三期临床实验结果发布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b662211418c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941570, encodeId=fed519415e021, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=在全球针对30多种癌症开展1300多项临床实验默沙东全力 “探索肿瘤治疗未来”, objectType=article, longId=203169, objectId=71e820316945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71e820316945, replyNumber=0, likeNumber=66, createdTime=2021-03-07, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71e820316945, moduleTitle=在全球针对30多种癌症开展1300多项临床实验默沙东全力 “探索肿瘤治疗未来”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=71e820316945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941568, encodeId=f34a1941568f1, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Clinica Chimica Acta：多重rRT-PCR检测SARS-CoV-2 RNA，用于临床实验室对COVID-19的分子诊断, objectType=article, longId=196309, objectId=226e1963099b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=226e1963099b, replyNumber=0, likeNumber=93, createdTime=2021-03-26, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=226e1963099b, moduleTitle=Clinica Chimica Acta：多重rRT-PCR检测SARS-CoV-2 RNA，用于临床实验室对COVID-19的分子诊断, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=226e1963099b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941571, encodeId=17d319415e1b6, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=获批上市还是前功尽弃？盘点2021年上半年值得关注的10个临床实验, objectType=article, longId=206410, objectId=2c64206410bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c64206410bc, replyNumber=0, likeNumber=67, createdTime=2021-06-29, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c64206410bc, moduleTitle=获批上市还是前功尽弃？盘点2021年上半年值得关注的10个临床实验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2c64206410bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941567, encodeId=7aec194156eb8, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功, objectType=article, longId=192743, objectId=597a192e43e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597a192e43e8, replyNumber=0, likeNumber=73, createdTime=2021-02-09, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597a192e43e8, moduleTitle=Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=597a192e43e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941569, encodeId=77da1941569fc, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Clinica Chimica Acta：评价两种血清游离轻链定量方法并在临床实验室进行转换免疫分析, objectType=article, longId=199106, objectId=60ef199106d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60ef199106d6, replyNumber=0, likeNumber=74, createdTime=2021-01-12, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60ef199106d6, moduleTitle=Clinica Chimica Acta：评价两种血清游离轻链定量方法并在临床实验室进行转换免疫分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=60ef199106d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941565, encodeId=b9041941565dd, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=CLIN CHEM LAB MED：六种适用于临床实验室的血清外泌体分离方法对细胞因子分析的影响的比较, objectType=article, longId=183130, objectId=b17a18313092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b17a18313092, replyNumber=0, likeNumber=90, createdTime=2019-11-26, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b17a18313092, moduleTitle=CLIN CHEM LAB MED：六种适用于临床实验室的血清外泌体分离方法对细胞因子分析的影响的比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b17a18313092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941566, encodeId=a73519415662f, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, objectType=article, longId=187845, objectId=85b418e84596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85b418e84596, replyNumber=0, likeNumber=64, createdTime=2020-12-22, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85b418e84596, moduleTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=85b418e84596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941563, encodeId=f0b9194156311, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=ARCH PATHOL LAB MED：利用机器学习简化临床实验室中质谱数据的质量审查, objectType=article, longId=181785, objectId=7379181e85ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7379181e85ee, replyNumber=0, likeNumber=80, createdTime=2020-06-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7379181e85ee, moduleTitle=ARCH PATHOL LAB MED：利用机器学习简化临床实验室中质谱数据的质量审查, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7379181e85ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941562, encodeId=66fc1941562fd, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=开立医疗自主研发超声内窥镜完成临床实验并获欧盟CE认证, objectType=article, longId=180840, objectId=3c6618084097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c6618084097, replyNumber=0, likeNumber=71, createdTime=2020-04-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c6618084097, moduleTitle=开立医疗自主研发超声内窥镜完成临床实验并获欧盟CE认证, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3c6618084097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941561, encodeId=1d1c1941561fc, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=疟疾治癌症？钟南山：下结论太早陈小平该项研究团队正在招募第二批患者参与临床实验, objectType=article, longId=160021, objectId=b3391600215a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3391600215a, replyNumber=0, likeNumber=79, createdTime=2019-07-23, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3391600215a, moduleTitle=疟疾治癌症？钟南山：下结论太早陈小平该项研究团队正在招募第二批患者参与临床实验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b3391600215a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941564, encodeId=aa4819415647b, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=礼来表示没有计划重新审查其阿兹海默氏药物索拉珠单抗已经失败的III期临床实验, objectType=article, longId=181882, objectId=a91918188212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91918188212, replyNumber=0, likeNumber=62, createdTime=2020-07-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91918188212, moduleTitle=礼来表示没有计划重新审查其阿兹海默氏药物索拉珠单抗已经失败的III期临床实验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a91918188212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941558, encodeId=e9af194155890, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=CCLM：常规临床实验室对巨泌乳素的观察性研究, objectType=article, longId=145628, objectId=b68214562869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b68214562869, replyNumber=0, likeNumber=69, createdTime=2018-12-01, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b68214562869, moduleTitle=CCLM：常规临床实验室对巨泌乳素的观察性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b68214562869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941557, encodeId=e417194155e5a, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=境外临床实验数据共享，进口药或将大降价, objectType=article, longId=144124, objectId=95d414412488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95d414412488, replyNumber=0, likeNumber=87, createdTime=2018-09-19, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95d414412488, moduleTitle=境外临床实验数据共享，进口药或将大降价, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=95d414412488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941560, encodeId=e3631941560be, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=广州一患者参加药物临床实验后死亡，医院研究方应如何担责？, objectType=article, longId=155038, objectId=207c155038de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=207c155038de, replyNumber=0, likeNumber=66, createdTime=2019-09-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=207c155038de, moduleTitle=广州一患者参加药物临床实验后死亡，医院研究方应如何担责？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=207c155038de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941559, encodeId=b5211941559ce, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=每月注射一次的长效HIV疗法cabotegravir/rilpivirine III期临床实验喜获成功, objectType=article, longId=146747, objectId=d9eb146e4766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9eb146e4766, replyNumber=0, likeNumber=59, createdTime=2019-06-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9eb146e4766, moduleTitle=每月注射一次的长效HIV疗法cabotegravir/rilpivirine III期临床实验喜获成功, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d9eb146e4766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941556, encodeId=32991941556f8, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Anesthesiology：胸段硬膜外麻醉中罗哌卡因与布比卡因分别对下尿路功能的影响：随机临床实验, objectType=article, longId=132029, objectId=5839132029be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5839132029be, replyNumber=0, likeNumber=61, createdTime=2018-11-17, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5839132029be, moduleTitle=Anesthesiology：胸段硬膜外麻醉中罗哌卡因与布比卡因分别对下尿路功能的影响：随机临床实验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5839132029be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941554, encodeId=299e1941554f9, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Anesthesiology：产科硬膜外麻醉---芬太尼剂量和母乳喂养成功的关系:随机临床实验, objectType=article, longId=119874, objectId=53de1198e424, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53de1198e424, replyNumber=0, likeNumber=64, createdTime=2018-01-28, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53de1198e424, moduleTitle=Anesthesiology：产科硬膜外麻醉---芬太尼剂量和母乳喂养成功的关系:随机临床实验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=53de1198e424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941551, encodeId=8448194155121, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=临床实验结果显示，Inovio公司HIV疫苗免疫响应率接近100%, objectType=article, longId=101052, objectId=67b410105255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67b410105255, replyNumber=0, likeNumber=0, createdTime=2017-10-07, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67b410105255, moduleTitle=临床实验结果显示，Inovio公司HIV疫苗免疫响应率接近100%, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=67b410105255)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

临床实验

2020-05-29

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

ASCO2022：机会之窗临床实验，胶质母细胞瘤的曙光

2022-06-24

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Nat Med：摇头丸治疗创伤后应激障碍PTSD的三期临床实验结果发布

2021-06-21

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

在全球针对30多种癌症开展1300多项临床实验默沙东全力 “探索肿瘤治疗未来”

2021-03-07

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Clinica Chimica Acta：多重rRT-PCR检测SARS-CoV-2 RNA，用于临床实验室对COVID-19的分子诊断

2021-03-26

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

获批上市还是前功尽弃？盘点2021年上半年值得关注的10个临床实验

2021-06-29

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功

2021-02-09

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Clinica Chimica Acta：评价两种血清游离轻链定量方法并在临床实验室进行转换免疫分析

2021-01-12

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

CLIN CHEM LAB MED：六种适用于临床实验室的血清外泌体分离方法对细胞因子分析的影响的比较

2019-11-26

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败

2020-12-22

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

ARCH PATHOL LAB MED：利用机器学习简化临床实验室中质谱数据的质量审查

2020-06-06

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

开立医疗自主研发超声内窥镜完成临床实验并获欧盟CE认证

2020-04-06

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

疟疾治癌症？钟南山：下结论太早陈小平该项研究团队正在招募第二批患者参与临床实验

2019-07-23

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

礼来表示没有计划重新审查其阿兹海默氏药物索拉珠单抗已经失败的III期临床实验

2020-07-06

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

CCLM：常规临床实验室对巨泌乳素的观察性研究

2018-12-01

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

境外临床实验数据共享，进口药或将大降价

2018-09-19

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

广州一患者参加药物临床实验后死亡，医院研究方应如何担责？

2019-09-06

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

每月注射一次的长效HIV疗法cabotegravir/rilpivirine III期临床实验喜获成功

2019-06-06

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Anesthesiology：胸段硬膜外麻醉中罗哌卡因与布比卡因分别对下尿路功能的影响：随机临床实验

2018-11-17

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Anesthesiology：产科硬膜外麻醉---芬太尼剂量和母乳喂养成功的关系:随机临床实验

2018-01-28

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

临床实验结果显示，Inovio公司HIV疫苗免疫响应率接近100%

2017-10-07

科室
- - 订阅+
  - 更多科室
工具
服务